ADAM9 and familial pancreatic carcinoma: asserted that upregulation of miR-126 in connection with the knockdown of ADAM9 leads to a reduction in cellular metastasis and invasion in pancreatic cancer, highlighting the crucial role of the miR-126/ADAM9 axis in inhibiting the invasive growth of pancreatic cancer cell lines.